Optic neuritis following Varicella zoster vaccination: Report of two cases

Vaccine

Volumn 32, Issue 39, 2014, Pages 4881-4884

  Han, Sang Beom ^a   Hwang, Jeong Min ^b   Kim, Ji Soo ^b   Yang, Hee Kyung ^b  

^a Kangwon National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Optic neuritis; Varicella zoster virus vaccination

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; VARICELLA ZOSTER VACCINE; CHICKENPOX VACCINE;

ADULT; ARTICLE; CASE REPORT; COLOR VISION; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HERPES ZOSTER; HUMAN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPTIC NEURITIS; PRIORITY JOURNAL; RECURRENT DISEASE; VACCINATION; VARICELLA ZOSTER VIRUS; VISUAL FIELD DEFECT; ADVERSE EFFECTS; CHEMICALLY INDUCED;

ADULT; CHICKENPOX VACCINE; FEMALE; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; OPTIC NEURITIS; PREDNISOLONE; VACCINATION;

EID: 84906081172     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.023     Document Type: Article

References (20)

1. Gagliardi A.M., Gomes Silva B.N., Torloni M.R., Soares B.G. Vaccines for preventing Herpes zoster in older adults. Cochrane Database Syst Rev 2012, 10:CD008858.
2. Donahue J.G., Kieke B.A., Yih W.K., Berger N.R., McCauley J.S., Baggs J., et al. Varicella vaccination and ischemic stroke in children: is there an association?. Pediatrics 2009, 123(2):e228-e234.
3. Kelly W.N., Arellano F.M., Barnes J., Bergman U., Edwards I.R., Fernandez S.B., et al. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007, 16(5):581-587.
4. Karussis D., Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 2014, 13(3):215-224.
5. Stubgen J.P. A literature review on optic neuritis following vaccination against virus infections. Autoimmun Rev 2013, 12(10):990-997.
6. Kerrison J.B., Lounsbury D., Thirkill C.E., Lane R.G., Schatz M.P., Engler R.M. Optic neuritis after anthrax vaccination. Ophthalmology 2002, 109(1):99-104.
7. Jacob A., McKeon A., Nakashima I., Sato D.K., Elsone L., Fujihara K., et al. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol, Neurosurg, Psychiatry 2013, 84(8):922-930.
8. Petzold A., Plant G.T. Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev 2014, 13(4-5):539-545.
9. Nilsson P., Larsson E.M., Maly-Sundgren P., Perfekt R., Sandberg-Wollheim M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol 2005, 252(4):396-402.
10. Ebner R. Dysthyroid optic neuropathy (DON). Semin Ophthalmol 2002, 17(1):18-21.
11. Tektonidou M.G., Anapliotou M., Vlachoyiannopoulos P., Moutsopoulos H.M. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 2004, 63(9):1159-1161.
12. Richardson B., Epstein W.V. Utility of the fluorescent antinuclear antibody test in a single patient. Ann Intern Med 1981, 95(3):333-338.
13. Halsey N.A., Edwards K.M., Dekker C.L., Klein N.P., Baxter R., Larussa P., et al. Algorithm to assess causality after individual adverse events following immunizations. Vaccine 2012, 30(39):5791-5798.
14. Williams S.E., Pahud B.A., Vellozzi C., Donofrio P.D., Dekker C.L., Halsey N., et al. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 2011, 29(46):8302-8308.
15. Schattner A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005, 23(30):3876-3886.
16. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5(11):648-652.
17. Koppang E.O., Bjerkas I., Haugarvoll E., Chan E.K., Szabo N.J., Ono N., et al. Vaccination-induced systemic autoimmunity in farmed Atlantic salmon. J Immunol 2008, 181(7):4807-4814.
18. Baxter R., Tran T.N., Hansen J., Emery M., Fireman B., Bartlett J., et al. Safety of Zostavax-a cohort study in a managed care organization. Vaccine 2012, 30(47):6636-6641.
19. Sadzot-Delvaux C., Rentier B., Wutzler P., Asano Y., Suga S., Yoshikawa T., et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis 2008, 197(Suppl. 2):S185-S190.
20. Pahud B.A., Williams S.E., Dekker C.L., Halsey N., Larussa P., Baxter R.P., et al. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J 2013, 32(2):163-168.